Prospective Five-Year Follow-Up of Patients with Schizophrenia Suspected with Parkinson’s Disease

Figure 1

Follow-up findings. (a) Total Movement Disorder Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS), (b) daily levodopa dose, and (c) average specific binding ratio of dopamine transporter imaging.

(a)

(b)

(c)